期刊文献+

VHL基因突变与肾透明细胞癌CT影像学特点的相关性研究

The correlational research on VHL gene mutation and CT imageing manifestations of renal clear cell carcinoma
下载PDF
导出
摘要 目的探讨(von hippel-lindau,VHL)基因与肾透明细胞癌CT影像学特点的关系。方法本研究以中国肾透明细胞癌患者为研究对象,提取基因组DNA、应用聚合酶链反应扩增VHL基因片段后进行Sanger测序,结合CT影像学表现进行相关分析。结果 98例肾透明细胞癌患者纳入本研究,其中53例(54.1%)患者存在VHL基因突变。VHL基因突变在肿瘤边缘清晰(P=0.041)与否及肿瘤内是否有新生血管形成(P=0.006)有显著差异。结论 VHL基因突变可影响肾透明细胞癌CT影像学表现。 Objective To investigate the relationship between Von Hippel‐Lindau (VHL) gene and the CT imaging char‐acteristics of renal clear cell carcinoma .Methods This research was conducted to understand renal clear cell carcinoma pa‐tients in China with the genomic DNA extraction ,and analyzed the VHLgenetic fragment amplified by Polymerase Chain Reaction (PCR) based Sanger sequencing ,and compared with CT imaging .Results In all ,98 renal clear cell carcinoma patients were identified ,VHL gene mutation was detected in 53(54 .1% ) of eligible patients .VHL gene mutation around the tumor tissue with a clear edge or not ( P=0 .041) showed significant difference from neovascularization ( P=0 .006) . Conclusion VHL gene mutation could affect CT imageing manifestations of renal clear cell carcinoma .
出处 《医学影像学杂志》 2014年第11期1954-1956,共3页 Journal of Medical Imaging
关键词 VHL基因 肾透明细胞癌 体层摄影术 X线计算机 Sanger测序 VHLgene Renal clear cell carcinoma Tomography,X-ray computed Sanger sequencing
  • 相关文献

参考文献7

  • 1Kashyap MK, Kumar A, Emelianenko N, et al. Biochemical and molecular markers in renal cell carcinema: an update and future prospects [J]. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals, 2005, 10(4) : 258-294.
  • 2吴小光,杨宏远,刘建平.CT在不同病理亚型肾细胞癌诊断中的价值[J].医学影像学杂志,2014,24(3):417-420. 被引量:15
  • 3Bodmer D, van den Hurk W, van Groningen JJ, et al. Un- derstanding familial and non-familial renal cell cancer [J]: Human Molecular Genetics, 2002, 11(20) : 2489-2498.
  • 4Yao M, Yoshida M, Kishida T, et al. VHL tumor suppres- sor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma [J]. Journal of the National Cancer Institute, 2002, 94(20): 1569-1575.
  • 5Magnasco A, Corselli M, Bertelli R, et al. Mesenchymal stem cells protective effect in adriamycin model of nephropa- thy [J]. Cell transplantation, 2008, 17(10-11): 1157-1167.
  • 6Gordan JD, Lal P, Dondeti VR, et al. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma [J]. Cancer Cell, 2008, 14(6): 435-446.
  • 7Arias-Gonzalez L, Moreno-Gimeno I, del Campo AR, et al. ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma [J]. Neopla sia, 2013, 15(6): 649-659.

二级参考文献10

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部